{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:05:57Z","timestamp":1755036357233,"version":"3.41.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/25728-2"],"award-info":[{"award-number":["2015\/25728-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.lfs.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T23:46:13Z","timestamp":1521157573000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The role of organic cation transporter 2 inhibitor cimetidine, experimental diabetes mellitus and metformin on gabapentin pharmacokinetics in rats"],"prefix":"10.1016","volume":"200","author":[{"given":"Jhohann Richard de Lima","family":"Benzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila Akemi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Hanna","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda Martins","family":"Baviera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4389-058X","authenticated-orcid":false,"given":"Nat\u00e1lia Valadares","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.03.012_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.lfs.2018.03.012_bb0010","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2018.03.012_bb0015","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/bcpt.12567","article-title":"Antinociceptive interaction of tramadol with gabapentin in experimental mononeuropathic pain","volume":"119","author":"Miranda","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0020","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jpainsymman.2014.08.010","article-title":"Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease","volume":"49","author":"Cheikh Hassan","year":"2015","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.lfs.2018.03.012_bb0025","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1111\/j.1528-1157.1995.tb06001.x","article-title":"Gabapentin","volume":"36","author":"McLean","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2018.03.012_bb0030","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1528-1157.1999.tb00743.x","article-title":"Effects of age and gender on single-dose pharmacokinetics of gabapentin","volume":"40","author":"Boyd","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.lfs.2018.03.012_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0920-1211(01)00311-4","article-title":"Population pharmacokinetics of gabapentin in infants and children","volume":"47","author":"Ouellet","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.lfs.2018.03.012_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2125.2010.03616.x","article-title":"Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine","volume":"69","author":"Lal","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mam.2012.10.010","article-title":"The SLC22 family with transporters of organic cations, anions and zwitterions","volume":"34","author":"Koepsell","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.lfs.2018.03.012_bb0050","doi-asserted-by":"crossref","first-page":"800 LP","DOI":"10.1016\/S0022-3565(24)37859-0","article-title":"Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs","volume":"287","author":"Urakami","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2018.03.012_bb0055","first-page":"F679","article-title":"Localization of organic cation transporters OCT1 and OCT2 in rat kidney","volume":"279","author":"Karbach","year":"2000","journal-title":"Am. J. Phys. Renal Phys."},{"issue":"90","key":"10.1016\/j.lfs.2018.03.012_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1520-6017(200104)90:4<397::AID-JPS1000>3.0.CO;2-D","article-title":"Transporters involved n the elimination of drugs in the kidney: organic anion transporters and organic cation transporters","volume":"4","author":"Dresser","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2018.03.012_bb0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF03261926","article-title":"Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs","volume":"51","author":"Dostalek","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2018.03.012_bb0070","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.lfs.2007.07.032","article-title":"Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline","volume":"81","author":"Nadai","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.03.012_bb0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/00498254.2014.949904","article-title":"Investigation of the role of organic cation transporter 2 (OCT2) in the renal transport of guanfacine, a selective \u03b12A-adrenoreceptor agonist","volume":"45","author":"Li","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.lfs.2018.03.012_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/147323000803600116","article-title":"Functional involvement of the organic cation transporter 2 (rOct2) in the renal uptake of organic cations in rats","volume":"36","author":"Umehara","year":"2008","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.lfs.2018.03.012_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Consortium","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2018.03.012_bb0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF03261926","article-title":"Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs","volume":"51","author":"Dostalek","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.lfs.2018.03.012_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0076-6879(91)06102-9","article-title":"Induction of diabetes and evaluation of diabetic state on P450 expression","volume":"206","author":"Schenkman","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-3565(24)29525-2","article-title":"Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation","volume":"297","author":"Iber","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2018.03.012_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/187231208783478425","article-title":"Renal and hepatic transporter expression in type 2 diabetic rats","volume":"2","author":"Nowicki","year":"2008","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.lfs.2018.03.012_bb0110","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1124\/jpet.103.058388","article-title":"Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes","volume":"308","author":"Grover","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2018.03.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002966.pub3","article-title":"Metformin monotherapy for type 2 diabetes mellitus","volume":"20","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2018.03.012_bb0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1208\/s12248-013-9460-z","article-title":"Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects","volume":"15","author":"Yoon","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.lfs.2018.03.012_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2133\/dmpk.20.379","article-title":"Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1","volume":"20","author":"Kimura","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.lfs.2018.03.012_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2008.61","article-title":"Genetic variants of the organic cation transporter 2 influence the disposition of metformin","volume":"84","author":"Song","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.03.012_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes GOOD PRACTICE GUIDE FOR ADMINISTRATION OF SUBSTANCES","volume":"21","author":"Diehl","year":"2001","journal-title":"J. Appl. Toxicol. J. Appl. Toxicol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.jepm.2009.04.002","article-title":"Blood collection techniques in exotic small mammals","volume":"18","author":"Ott Joslin","year":"2009","journal-title":"J. Exot. Pet Med."},{"issue":"37","key":"10.1016\/j.lfs.2018.03.012_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/bdd.2041","article-title":"Metoprolol decreases the plasma exposure of metformin via the induction of liver, kidney and muscle uptake in rats","volume":"9","author":"Ma","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.lfs.2018.03.012_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113993","article-title":"Piperine, a natural bioenhancer, nullifies the antidiabetic and antioxidant activities of curcumin in streptozotocin-diabetic rats","volume":"9","author":"Arcaro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.03.012_bb0155","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.22.2.246-b","article-title":"Determination of blood glucose using 4-amino phenazone as oxygen acceptor","volume":"22","author":"Trinder","year":"1969","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0731-7085(03)00572-7","article-title":"Sample preparation and determination of gabapentin in venous and capillary blood using liquid chromatography-tandem mass spectrometry","volume":"34","author":"Carlsson","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.lfs.2018.03.012_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2006.03.011","article-title":"Sensitive high-performance liquid chromatographic quantitation of gabapentin in human serum using liquid-liquid extraction and pre-column derivatization with 9-fluorenylmethyl chloroformate","volume":"835","author":"Bahrami","year":"2006","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.lfs.2018.03.012_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jchromb.2007.03.039","article-title":"Validated HPLC method for the determination of gabapentin in human plasma using pre-column derivatization with 1-fluoro-2,4-dinitrobenzene and its application to a pharmacokinetic study","volume":"854","author":"Jalalizadeh","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.lfs.2018.03.012_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1248\/bpb.24.70","article-title":"Gaussian quadrature as a numerical integration method for estimating area under the curve","volume":"24","author":"Amisaki","year":"2001","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2018.03.012_bb0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pst.484","article-title":"A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies","volume":"11","author":"Navarro-Fontestad","year":"2012","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.lfs.2018.03.012_bb0185","first-page":"1","article-title":"Effect of inhalation exposure to toluene on the activity of organic anion transporting polypeptide (Oatp) using pravastatin as a probe drug in rats","volume":"0","author":"Mauro","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1016\/j.lfs.2018.03.012_bb0190","series-title":"34\u00b0 Congresso Nacional de Matem\u00e1tica Aplicada e Computacional","article-title":"Estima\u00e7\u00e3o da \u00e1rea sob a curva para dados farmacocin\u00e9ticos obtidos por amostragem esparsa","author":"Capela","year":"2012"},{"key":"10.1016\/j.lfs.2018.03.012_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.sjpain.2009.12.001","article-title":"Co-administered gabapentin and venlafaxine in nerve injured rats: effect on mechanical hypersensitivity, motor function and pharmacokinetics","volume":"1","author":"Folkesson","year":"2010","journal-title":"Scand J Pain"},{"key":"10.1016\/j.lfs.2018.03.012_bb0200","doi-asserted-by":"crossref","first-page":"441 LP","DOI":"10.1016\/S0090-9556(25)06578-X","article-title":"Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys","volume":"23","author":"Radulovic","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2018.03.012_bb0205","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11095-014-1505-1","article-title":"In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport","volume":"32","author":"Larsen","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2018.03.012_bb0210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.seizure.2015.02.017","article-title":"Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice","volume":"28","author":"Johannessen Landmark","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.lfs.2018.03.012_bb0215","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0014-5793(99)01491-X","article-title":"Gender differences in expression of organic cation transporter OCT2 in rat kidney","volume":"461","author":"Urakami","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2018.03.012_bb0220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1358\/mf.2006.28.4.990202","article-title":"Effects of oral administration of some herbal extracts on food consumption and blood glucose levels in normal and streptozotocin-treated diabetic rats","volume":"28","author":"Musabayane","year":"2006","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0225","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/jps.20744","article-title":"Dose-independent pharmacokinetics of metformin in rats: hepatic and gastrointestinal first-pass effects","volume":"95","author":"Choi","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2018.03.012_bb0230","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1139\/cjpp-2016-0329","article-title":"Pharmacokinetics of metformin in the rat: assessment of the effect of hyperlipidemia and evidence for its metabolism to guanylurea","volume":"95","author":"Gabr","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.lfs.2018.03.012_bb0235","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1046\/j.1523-1755.2003.00006.x","article-title":"Reduced tubular cation transport in diabetes: prevented by ACE inhibition","volume":"63","author":"Thomas","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2018.03.012_bb0240","first-page":"456","article-title":"The role of advanced glycation in reduced organic cation transport associated with experimental","volume":"311","author":"Thomas","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2018.03.012_bb0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vascn.2015.11.004","article-title":"Experimental diabetes induced by alloxan and streptozotocin: the current state of the art","volume":"78","author":"Radenkovi\u0107","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.lfs.2018.03.012_bb0250","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1463-1326.2007.00802.x","article-title":"Insulin therapy in renal disease","volume":"10","author":"Iglesias","year":"2008","journal-title":"Diabetes. Obes. Metab."},{"key":"10.1016\/j.lfs.2018.03.012_bb0255","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1152\/ajpregu.00582.2011","article-title":"Insulin induces the correlation between renal blood flow and glomerular filtration rate in diabetes: implications for mechanisms causing hyperfiltration","volume":"303","author":"Pihl","year":"2012","journal-title":"AJP Regul. Integr. Comp. Physiol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518301164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518301164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:47:24Z","timestamp":1751489244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518301164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":51,"alternative-id":["S0024320518301164"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.03.012","relation":{},"ISSN":["0024-3205"],"issn-type":[{"type":"print","value":"0024-3205"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of organic cation transporter 2 inhibitor cimetidine, experimental diabetes mellitus and metformin on gabapentin pharmacokinetics in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}